Physician profile
Eric Song
NPI 1083918403
$11,702.25
in general payments reported to CMS, 2019-2025
36 companies · $528 in 2025
The $528 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,461 · 2022: $1,693 · 2023: $1,274 · 2024: $747 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,299 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,298.72 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $5,428.56 | 2021-2025 | Emgality |
| Abbvie INC. | $1,278.42 | 2021-2025 | |
| Biodelivery Sciences International, INC. | $995.39 | 2021 | |
| Pfizer INC. | $576.53 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $390.37 | 2021-2025 | Relistor |
| Nevro Corp. | $324.19 | 2021-2024 | Senza |
| Electronic Waveform Lab, INC. | $260.98 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $220.73 | 2021-2023 | Belsomra |
| Almatica Pharma LLC | $211.63 | 2021-2023 | Gralise |
| Arbor Pharmaceuticals, INC. | $210.88 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $206.02 | 2022 | |
| Boston Scientific Corporation | $173.76 | 2021 | |
| Horizon Therapeutics Plc | $165.38 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $150.07 | 2022-2025 | Xeomin |
| Biohaven Pharmaceuticals, INC. | $148.43 | 2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $127.63 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $107.87 | 2021-2024 | Belbuca |
| Teva Pharmaceuticals USA, INC. | $70.53 | 2021-2022 | |
| Amgen INC. | $68.24 | 2021-2022 | |
| Allergan, INC. | $60.73 | 2022 | |
| Eisai INC. | $56.76 | 2021 | |
| Lundbeck LLC | $55.13 | 2021-2022 | |
| Abbott Laboratories | $46.27 | 2024 | Proclaim |
| Idorsia Pharmaceuticals US INC | $46.00 | 2022-2023 | Quviviq |
| Virtus Pharmaceuticals LLC | $45.75 | 2024-2025 | Levorphanol Tartrate |
| Tersera Therapeutics LLC | $38.95 | 2022 | |
| Supernus Pharmaceuticals, INC. | $35.33 | 2021 | |
| Spr Therapeutics, INC | $33.72 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $30.27 | 2021-2025 | |
| Fidia Pharma USA INC. | $24.17 | 2025 | Hymovis |
| Azurity Pharmaceuticals, INC. | $23.11 | 2023 | Horizant |
| Stimwave Technologies Incorporated | $22.88 | 2021 | |
| Redhill Biopharma INC. | $21.86 | 2021 | |
| Alnylam Pharmaceuticals INC. | $17.25 | 2021 | |
| Corcept Therapeutics | $16.23 | 2024 | Korlym |
| Relievant Medsystems, INC. | $12.23 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.